Wall Street Journal (subscription) |
Arizona Accuses Insys of Fraudulently Marketing Fentanyl Painkiller
Wall Street Journal (subscription) Insys Therapeutics Inc.'s legal woes worsened Thursday when the state of Arizona filed a lawsuit claiming the company improperly marketed a powerful opioid painkiller. Arizona's attorney general, Mark Brnovich, alleged in a suit filed early Thursday ... Arizona accuses Insys of fraudulent opioid marketing scheme |
August 31, 2017 at 11:39AM | marketing - Google News
Arizona Accuses Insys of Fraudulently Marketing Fentanyl Painkiller - Wall Street Journal (subscription)
marketing - Google News
Nenhum comentário:
Postar um comentário